Israel Biotech Fund logo

Israel Biotech Fund

Asia, HaMerkaz, Israel, Rehovot

Description

Israel Biotech Fund invests exclusively in biotech companies developing drugs at or near clinical stages.

Investor Profile

Israel Biotech Fund has made 7 investments, with 1 in the past 12 months and 71% as lead.

Stage Focus

  • Series B (29%)
  • Series Unknown (29%)
  • Series C (29%)
  • Series F (14%)

Country Focus

  • Israel (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical Device
  • Life Science
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Israel Biotech Fund frequently co-invest with?

Laborie Medical Technologies
North America, New Hampshire, United States, Portsmouth
Co-Investments: 2
SBI Japan-Israel Innovation Fund
Asia, Tel Aviv, Israel, Tel Aviv-yafo
Co-Investments: 1
Celgene
North America, New Jersey, United States, Summit
Co-Investments: 1
Migdal Insurance and Financial Holdings
Asia, HaMerkaz, Israel, Petah Tikwah
Co-Investments: 1
Harel Insurance and Financial
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
A
Europe, Worcestershire, United Kingdom, Bromsgrove
Co-Investments: 1
Co-Investments: 2
AB
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 1
Phoenix Financial
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 1
Trendlines Group
Asia, HaZafon, Israel, Misgav
Co-Investments: 1

Which angels does Israel Biotech Fund often collaborate with?

LP
North America, Pennsylvania, United States, Horsham
Shared Deals: 1

What are some of recent deals done by Israel Biotech Fund?

Vensica Medical

Misgav, HaZafon, Israel

Ultrasound Based Catheter For Improved Drug Delivery To The Bladder

Health CareMedical DeviceTherapeutics
Series UnknownOct 28, 2024
Amount Raised: $11,000,000
Vensica Medical

Misgav, HaZafon, Israel

Ultrasound Based Catheter For Improved Drug Delivery To The Bladder

Health CareMedical DeviceTherapeutics
Series UnknownNov 1, 2021
Amount Raised: $16,000,000
Splisense

Jerusalem, Yerushalayim, Israel

Splisense is develops antisense oligonucleotide based therapies to target genetic diseases caused by splicing mutations.

BiotechnologyLife SciencePharmaceutical
Series BMay 13, 2021
Amount Raised: $28,500,000
BioSight

Carmiel, HaZafon, Israel

Biosight is a private Phase 2 clinical stage biotech company developing innovative therapeutics for hematological.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CDec 2, 2020
Amount Raised: $27,000,000
Biond Biologics

Misgav, HaZafon, Israel

Biond Biologics is an Israeli biotechnology discovery and development company.

BiotechnologyHealth CarePharmaceutical
Series BJan 8, 2019
Amount Raised: $17,000,000
Gamida Cell

Jerusalem, Yerushalayim, Israel

Gamida Cell is a biopharmaceutical company developing advanced cell therapies for patients with blood cancers and hematologic diseases.

BiotechnologyHealth CareLife ScienceMedical DeviceTherapeutics
Series FJun 19, 2017
Amount Raised: $40,000,000
Pharma Two B

Rehovot, HaMerkaz, Israel

Pharma Two B develops clinical products based on approved drugs, focusing on fixed-dose-combinations of two or more drugs for PD and cancer.

BiopharmaBiotechnologyPharmaceutical
Series CFeb 27, 2017
Amount Raised: $30,000,000